Trophoblast Glycoprotein (TPGB/5T4) in Human Placenta: Expression, Regulation, and Presence in Extracellular Microvesicles and Exosomes

Reproductive Sciences

Volumn 25, Issue 2, 2018, Pages 185-197

  Alam, S M K ^a,b   Jasti, S ^a   Kshirsagar, S K ^c   Tannetta, D S ^d   Dragovic, R A ^d   Redman, C W ^d   Sargent, I L ^d   Hodes, H C ^e   Nauser, T L ^e   Fortes, T ^f,g   Filler, A M ^f,g   Behan, K ^g   Martin, D R ^f   Fields, T A ^a   Petroff, B K ^c   Petroff, M G ^a,c,h  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Center for Women's Health   (United States)

^f Claire Dart Stroke Center Sparrow Hospital   (United States)

^g MICHIGAN STATE UNIVERSITY   (United States)

^h NONE   (United States)

Author keywords

5T4; cancer; exosomes; microvesicles; placenta; trophoblast

Indexed keywords

CD63 ANTIGEN; CYTOKERATIN 7; DESMOPLAKIN; EPIDERMAL GROWTH FACTOR; GLYCOPROTEIN; MESSENGER RNA; OXYGEN; TROPHOBLAST GLYCOPROTEIN; TUBULIN; UNCLASSIFIED DRUG; MEMBRANE PROTEIN;

ARTICLE; BREAST CARCINOMA; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOTROPHOBLAST; EPITHELIAL MESENCHYMAL TRANSITION; EXOSOME; FEMALE; HEK293 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; MELANOMA; MEMBRANE MICROPARTICLE; MICROVILLUS; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNCYTIOTROPHOBLAST; THYMOMA; TROPHOBLAST; UTERUS; WESTERN BLOTTING; FIRST TRIMESTER PREGNANCY; GENETICS; METABOLISM; PHYSIOLOGY; PLACENTA DEVELOPMENT; PREGNANCY; SECOND TRIMESTER PREGNANCY;

CELL DIFFERENTIATION; EXOSOMES; EXTRACELLULAR VESICLES; FEMALE; HUMANS; MEMBRANE GLYCOPROTEINS; PLACENTA; PLACENTATION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; TROPHOBLASTS;

EID: 85038911256     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719117707053     Document Type: Article

References (54)

1. Pijnenborg R, Dixon G, Robertson WB, Brosens I. Trophoblast invasion of human decidua from 8-18 weeks of pregnancy. Placenta. 1980;1(1):3–19.
2. Harris LK, Aplin JD. Vascular remodeling and extracellular matrix breakdown in the uterine spiral arteries during pregnancy. Reprod Sci. 2007;14(suppl 8):28–34.
3. Bulmer JN, Innes BA, Levey J, Robson SC, Lash GE. The role of vascular smooth muscle cell apoptosis and migration during uterine spiral artery remodeling in normal human pregnancy. FASEB J. 2012;26(7):2975–2985.
4. Pijnenborg R, Robertson WB, Brosnens I, Dixon G. Review article: trophoblast invasion and the establishment of haemochorial placentation in man and laboratory animals. Placenta. 1981;2(1):71–91.
5. Murray MJ, Lessey BA. Embryo implantation and tumor metastasis: common pathways of invasion and angiogenesis. Semin Reprod Endocrinol. 1999;17(3):275–290.
6. Strickland S, Richards WG. Invasion of the trophoblasts. Cell. 1992;71(3):355–357.
7. Perry JK, Lins RJ, Lobie PE, Mitchell MD. Regulation of invasive growth: similar epigenetic mechanisms underpin tumor progression and implantation in human pregnancy. Clin Sci (Lond). 2010;118(7):451–457.
8. Jordan NV, Johnson GL, Abell AN. Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer. Cell Cycle. 2011;10(17):2865–2873.
9. Wilczynski JR. Cancer and pregnancy share similar mechanisms of immunological escape. Chemotherapy. 2006;52(3):107–110.
10. Jungbluth AA, Silva WA, JrIversen K. Expression of cancer-testis (CT) antigens in placenta. Cancer Immun. 2007;7:15.
11. Koslowski M, Sahin U, Mitnacht-Kraus R, Seitz G, Huber C, Türeci O. A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes. Cancer Res. 2007;67(19):9528–9534.
12. Butterfield LH. Cancer vaccines. BMJ. 2015;350:h988.
13. Hole N, Stern PL. A 72 kD trophoblast glycoprotein defined by a monoclonal antibody. Br J Cancer. 1988;57(3):239–246.
14. King KW, Sheppard FC, Westwater C, Stern PL, Myers KA. Organisation of the mouse and human 5T4 oncofoetal leucine-rich glycoprotein genes and expression in foetal and adult murine tissues. Biochim Biophys Acta. 1999;1445(3):257–270.
15. Myers KA, Rahi-Saund V, Davison MD, Young JA, Cheater AJ, Stern PL. Isolation of a cDNA encoding 5T4 oncofetal trophoblast glycoprotein. An antigen associated with metastasis contains leucine-rich repeats. J Biol Chem. 1994;269(12):9319–9324.
16. Kobe B, Kajava AV. The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol. 2001;11(6):725–732.
17. Awan A, Lucic MR, Shaw DM. 5T4 interacts with TIP-2/GIPC, a PDZ protein, with implications for metastasis. Biochem Biophys Res Commun. 2002;290(3):1030–1036.
18. Carsberg CJ, Myers KA, Stern PL. Metastasis-associated 5T4 antigen disrupts cell-cell contacts and induces cellular motility in epithelial cells. Int J Cancer. 1996;68(1):84–92.
19. Kagermeier-Schenk B, Wehner D, Özhan-Kizil G. Waif1/5T4 inhibits Wnt/β-catenin signaling and activates noncanonical Wnt pathways by modifying LRP6 subcellular localization. Devel Cell. 2011;21(6):1129–1143.
20. Mitchell PJ, Welton J, Staffurth J. Can urinary exosomes act as treatment response markers in prostate cancer? J Transl Med. 2009;7:4.
21. Petroff MG, Phillips TA, Ka H, Pace JL, Hunt JS. Isolation and culture of term human trophoblast cells. Methods Mol Med. 2006;121:203–217.
22. Holets LM, Carletti MZ, Kshirsagar SK, Christenson LK, Petroff MG. Differentiation-induced post-transcriptional control of B7-H1 in human trophoblast cells. Placenta. 2009;30(1):48–55.
23. Graham CH, Hawley TS, Hawley RG. Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res. 1993;206(2):204–211.
24. Straszewski-Chavez SL, Abrahams VM, Alvero AB. The isolation and characterization of a novel telomerase immortalized first trimester trophoblast cell line, Swan 71. Placenta. 2009;30(11):939–948.
25. Thery C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol. 2006;Chapter 3:Unit 3 22.
26. Kshirsagar SK, Alam SM, Jasti S. Immunomodulatory molecules are released from the first trimester and term placenta via exosomes. Placenta. 2012;33(12):982–990.
27. Dragovic RA, Gardiner C, Brooks AS. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine. 2011;7(6):780–788.
28. Dragovic RA, Collett GP, Hole P. Isolation of syncytiotrophoblast microvesicles and exosomes and their characterisation by multicolour flow cytometry and fluorescence Nanoparticle Tracking Analysis. Methods. 2015;87:64–74.
29. Holets LM, Hunt JS, Petroff MG. Trophoblast CD274 (B7-H1) is differentially expressed across gestation: influence of oxygen concentration. Biol Reprod. 2006;74(2):352–358.
30. Linscheid C, Heitmann E, Singh P. Trophoblast expression of the minor histocompatibility antigen HA-1 is regulated by oxygen and is increased in placentas from preeclamptic women. Placenta. 2015;36(8):832–838.
31. Morrish DW, Bhardwaj D, Dabbagh LK, Marusyk H, Siy O. Epidermal growth factor induces differentiation and secretion of human chorionic gonadotropin and placental lactogen in normal human placenta. J Clin Endocrinol Metab. 1987;65(6):1282–1290.
32. Morrish DW, Dakour J, Li H. Functional regulation of human trophoblast differentiation. J Reprod Immunol. 1998;39(1-2):179–195.
33. Jaffe R, Jauniaux E, Hustin J. Maternal circulation in the first-trimester human placenta—myth or reality? Am J Obstet Gynecol. 1997;176(3):695–705.
34. Carsberg CJ, Myers KA, Evans GS, Allen TD, Stern PL. Metastasis-associated 5T4 oncofoetal antigen is concentrated at microvillus projections of the plasma membrane. J Cell Sci. 1995;108(pt 8):2905–2916.
35. Roberts JM, Escudero C. The placenta and preeclampsia. Pregnancy Hypertens. 2012;2(2):72–83.
36. Raposo G, Nijman HW, Stoorvogel W. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183(3):1161–1172.
37. Hole N, Stern PL. Isolation and characterization of 5T4, a tumor-associated antigen. Int J Cancer. 1990;45(1):179–184.
38. Southall PJ, Boxer GM, Bagshawe KD, Hole N, Bromley M, Stern PL. Immunohistological distribution of 5T4 antigen in normal and malignant tissues. Br J Cancer. 1990;61(1):89–95.
39. Kokkinos MI, Murthi P, Wafai R, Thompson EW, Newgreen DF. Cadherins in the human placenta—epithelial–mesenchymal transition (EMT) and placental development. Placenta. 2010;31(9):747–755.
40. Southgate TD, McGinn OJ, Castro FV. CXCR4 mediated chemotaxis is regulated by 5T4 oncofetal glycoprotein in mouse embryonic cells. PLoS One. 2010;5(4):e9982.
41. McGinn OJ, Marinov G, Sawan S, Stern PL. CXCL12 receptor preference, signal transduction, biological response and the expression of 5T4 oncofoetal glycoprotein. J Cell Sci. 2012;125(pt 22):5467–5478.
42. Zhao Y, Malinauskas T, Harlos K, Jones EY. Structural insights into the inhibition of Wnt signaling by cancer antigen 5T4/Wnt-activated inhibitory factor 1. Structure. 2014;22(4):612–620.
43. Schanz A, Baston-Bust D, Krussel JS, Heiss C, Janni W, Hess AP. CXCR7 and syndecan-4 are potential receptors for CXCL12 in human cytotrophoblasts. J Reprod Immunol. 2011;89(1):18–25.
44. Schanz A, Red-Horse K, Hess AP, Baston-Büst DM, Heiss C, Krüssel JS. Oxygen regulates human cytotrophoblast migration by controlling chemokine and receptor expression. Placenta. 2014;35(12):1089–1094.
45. Pollheimer J, Loregger T, Sonderegger S. Activation of the canonical wingless/T-Cell factor signaling pathway promotes invasive differentiation of human trophoblast. Am J Pathol. 2006;168(4):1134–1147.
46. Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ. Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol. 2000;157(6):2111–2122.
47. Nelson DM, Johnson RD, Smith SD, Anteby EY, Sadovsky Y. Hypoxia limits differentiation and up-regulates expression and activity of prostaglandin H synthase 2 in cultured trophoblast from term human placenta. Am J Obstet Gynecol. 1999;180(4):896–902.
48. Welton JL, Khanna S, Giles PJ. Proteomics analysis of bladder cancer exosomes. Mol Cell Proteomics. 2010;9(6):1324–1338.
49. Stenqvist AC, Nagaeva O, Baranov V, Mincheva-Nilsson L. Exosomes secreted by human placenta carry functional Fas ligand and TRAIL molecules and convey apoptosis in activated immune cells, suggesting exosome-mediated immune privilege of the fetus. J Immunol. 2013;191(11):5515–5523.
50. Taylor DD, Akyol S, Gercel-Taylor C. Pregnancy-associated exosomes and their modulation of T cell signaling. J Immunol. 2006;176(3):1534–1542.
51. Wolfers J, Lozier A, Raposo G. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med. 2001;7(3):297–303.
52. Erlebacher A, Vencato D, Price KA, Zhang D, Glimcher LH. Constraints in antigen presentation severely restrict T cell recognition of the allogeneic fetus. J Clin Invest. 2007;117(5):1399–1411.
53. Moldenhauer LM, Diener KR, Thring DM, Brown MP, Hayball JD, Robertson SA. Cross-presentation of male seminal fluid antigens elicits T cell activation to initiate the female immune response to pregnancy. J Immunol. 2009;182(12):8080–8093.
54. Abumaree MH, Stone PR, Chamley LW. The effects of apoptotic, deported human placental trophoblast on macrophages: Possible consequences for pregnancy. J Reprod Immunol. 2006;72(1-2):33–45.